Form 4 for DGX Quest Diagnostics
Accepted 2023-02-27 00:00:00 ET · period of report 2023-02-23 · accession 0001022079-23-000034 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-27 | 2023-02-23 | DGX | Plewman Patrick | SVP for Diagnostic Services | A - Grant | $0.00 | +1,919 | 10.7K | +22% | $0 |
| D | 2023-02-27 | 2023-02-23 | DGX | Plewman Patrick | SVP for Diagnostic Services | F - Tax | $147.86 | -245 | 8,737 | -3% | -$36.2K |
| D | 2023-02-27 | 2023-02-23 | DGX | Plewman Patrick | SVP for Diagnostic Services | A - Grant | $0.00 | +7,584 | 7,584 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-23 | A | A | 1,919 | $0.00 | 10,656 | D | — | — | (F3) Represents an award of restricted share units. |
| 2 | Common | Common Stock | 2023-02-23 | F | D | 245 | $147.86 | 8,737 | D | — | — | (F1) Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. (F2) The amount includes exempt purchases made under the Company's stock purchase plan. |
| 3 | Derivative | Non-Qualifed Stock Option (right to buy) | 2023-02-23 | A | A | 7,584 | $0.00 | 7,584 | D | $143.33 · — to 2033-02-23 | 7,584 Common Stock | (F4) The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. |